{"id":"W4290993146","doi":"10.1016/j.esmoop.2022.100553","title":"Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer","year":2022,"lang":"en","type":"review","venue":"ESMO Open","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Lilly Deutschland; Merck Sharp and Dohme; Eisai; Clovis Oncology; Boehringer Ingelheim; Ariad Pharmaceuticals; Roche; Daiichi-Sankyo; Teva Pharmaceutical Industries; Novartis; Merck; Sanofi-Aventis Deutschland; Pfizer; Queen Mary University of London; Bristol-Myers Squibb; AstraZeneca; Gilead Sciences","keywords":"Medicine; Breast cancer; Trastuzumab; Internal medicine; Pneumonitis; Nausea; Context (archaeology); Neutropenia; Oncology; Metastatic breast cancer; Cancer; Chemotherapy; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003110049,0.0002540244,0.0004767287,0.0006965223,0.0002612563,0.001062493,0.000609775,0.0007632301,0.002371256],"category_scores_gemma":[0.008121382,0.0001134822,0.0004603983,0.000747673,0.0003046325,0.0009322824,0.000637471,0.0009692222,0.0006904004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001281721,"about_ca_system_score_gemma":0.002581315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001187728,"about_ca_topic_score_gemma":0.003242972,"domain_scores_codex":[0.9979675,0.001059312,0.0003469469,0.0001229983,0.0004152487,0.000088074],"domain_scores_gemma":[0.9969318,0.001050586,0.0008287897,0.00006029306,0.0009252839,0.0002031228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001458575,0.00006094637,0.002692385,0.006677965,0.0001099716,0.0003328097,0.0002903624,0.0006516619,0.0007390928,0.003332517,0.0659524,0.9190141],"study_design_scores_gemma":[0.0002295354,0.0003588948,0.008650057,0.01983669,0.0003286974,0.003031188,0.0005091101,0.0007057012,0.001122988,0.004495641,0.9606938,0.00003771808],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00719339,0.9142903,0.004379408,0.04639721,0.00137542,0.000189283,0.0001657883,0.000104232,0.02590496],"genre_scores_gemma":[0.06670319,0.8932126,0.01468866,0.01798227,0.002874483,0.0003093563,0.0004422838,0.00004197088,0.003745238],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003110049,"threshold_uncertainty_score":0.01644772,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3380420165733111,"score_gpt":0.5932876732972931,"score_spread":0.2552456567239821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}